Applied Biosystems has announced the worldwide commercial availability of the SOLiD system, the companyÆs nextgeneration DNA sequencing platform.
This new era of life-science research calls for technologies that can help scientists identify how genetic variation and patterns of gene expression contribute to disease, the manner in which individual genotypes impact, and how people may respond to various treatments. The SOLiD system is distinguished by unparallelled throughput, scalability, accuracy and application flexibility.
Applied Biosystems www.appliedbiosystems.com